Protocol Guide: mRNA Vaccine QC for Sanger Sequencing Workflows


Boosting sequencing accuracy and efficiency for mRNA vaccine development


mRNA vaccines generated a great deal of excitement and interest following their success in combating the SARS-CoV-2 crisis. The vaccines are a relatively straightforward method for introducing immunogenic mRNA sequences into host cells to combat infectious diseases and hold great potential for cancer research applications.

This protocol guide outlines quality control (QC) procedures for verifying nucleic acid sequences at various stages of mRNA vaccine production using Sanger sequencing. It details three distinct Sanger sequencing workflows—Direct Sanger sequencing, BigDye Direct cycle sequencing, and BigDye Terminator v3.1 with ExoSAP-IT—to verify vector sequences, plasmid DNA, and transcribed mRNA.

Key takeaways

  • Direct Sanger Sequencing, without intermediate PCR amplification, can increase efficiency and reduce polymerase-introduced errors.
  •         BigDye Direct Chemistry, which combines PCR cleanup and sequencing, can simplify hands-on time and overall processing.
  •         Clear Quality Control Criteria can provide actionable metrics to ensure high-confidence results.
  •         Comprehensive Hardware and Software Compatibility can integrate precise protocols with tailored runs across multiple sequencing and analysis workflows.

Download this essential mRNA vaccine protocols guide and take control of your mRNA sequencing quality control workflows.

DOWNLOAD THIS FREE GUIDE TO LEARN MORE

Become a member and enjoy exclusive benefits

Create an account now for exclusive benefits, personalized recommendations, and seamless order tracking. Elevate your lab experience today!